Genitourinary Radiology: Page 70

Contrast media add valuable information in US applications
By Erik L. Ridley
ATLANTIC CITY - Ultrasound contrast media is useful in many radiological applications and helps clinical practice, according to Dr. Yuko Kono of the University of California, San Diego (UCSD). She spoke Thursday during a session at this week's 2007 Leading Edge in Diagnostic Ultrasound conference.
May 3, 2007
B-K Medical launches new probe
By AuntMinnie.com staff writers
Analogic subsidiary B-K Medical has launched its new 8848 transducer for prostate brachytherapy and pelvic floor scanning in women.
May 2, 2007
MDS Nordion reports glitch in iodine-131 supply
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion of Kanata, Ontario, has reported an interruption in supply of iodine-131, an isotope commonly used in nuclear medicine procedures.
April 19, 2007
IsoRay continues cesium-131 placements
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical reported that market acceptance of its cesium-131 brachytherapy products continued to advance.
April 4, 2007
MRI pioneer Lauterbur dies
Paul Lauterbur, Ph.D., who received the Nobel Prize for his role in developing MRI, died on Tuesday at his home in Illinois of kidney disease. He was 77.
March 29, 2007
Pennsylvania issues contrast-induced nephropathy guidance
By AuntMinnie.com staff writers
The Pennsylvania Patient Safety Reporting System (PA-PSRS) has issued a supplementary patient safety advisory along with its quarterly 2007 March patient safety advisory to raise awareness of contrast-induced nephropathy (CIN).
March 29, 2007
Misonix reports HIFU hemiablation success
By AuntMinnie.com staff writers
Ultrasound technology developer Misonix announced promising results for the firm's Sonablate 500 high-intensity focused ultrasound (HIFU) clinical trial in the U.K. for hemiablation procedures for prostate cancer treatment.
March 28, 2007
Misonix establishes HIFU clinical registry
By AuntMinnie.com staff writers
Ultrasound technology developer Misonix has launched a global high-intensity focused ultrasound (HIFU) prostate cancer treatment clinical registry.
March 26, 2007
Gadolinium: A 'necessary factor' in the development of NSF?
By Sydney Schuster
Could gadolinium-based contrast agents be the next Vioxx? The hundreds of people stricken with nephrogenic systemic fibrosis (NSF) -- allegedly after receiving the contrast medium for an MR exam -- might think so, not to mention the lawyers who are courting them. But how strong is the link between NSF and gadolinium chelates? While the scientific community untangles how this devastating disease became associated with a commonplace tool in the MR armamentarium, imaging professionals should be on guard.
March 26, 2007
2007 03 26 15 26 17 706
ASCO study: Rising PSA, not imaging results, predicts prostate cancer relapse
Clinicians are ordering up imaging exams for pinpointing metastatic prostate tumors, but the results are not likely to be helpful unless prostate-specific antigen (PSA) levels are about 5 ng/mL and/or the PSA doubling time is greater than 10 months, according to a presentation at the 2007 Prostate Cancer Symposium.
March 25, 2007
Misonix reports HIFU kidney trial success
By AuntMinnie.com staff writers
Ultrasound technology developer Misonix said that results for the firm's Sonatherm 600 high-intensity focused ultrasound (HIFU) clinical trials for kidney cancer were promising.
March 21, 2007
Tyco hit with lawsuit over gadolinium reaction
By AuntMinnie.com staff writers
A Cleveland man who claims he developed nephrogenic systemic fibrosis (NSF) from an injection of gadolinium MRI contrast has filed a lawsuit against Tyco International of Pembroke, Bermuda, and two of its subsidiaries, Tyco Healthcare Group and Mallinckrodt of Hazelwood, MO.
March 18, 2007
Previous Page
Page 70 of 93
Next Page